Work

Abstract PS2-07-12: Gut microbiome composition predicts pathologic complete response in patients with early-stage HER2-positive breast cancer receiving neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-07-12

Authors: A. LeVee, K. Lee, S. Rice, I. Chan, S. Sridharan, S. Shiao, S. Pal, H. McArthur

Institutions: University of California, Los Angeles, Translational Genomics Research Institute, The University of Texas Southwestern Medical Center, Cedars-Sinai Medical Center, City Of Hope National Medical Center, City of Hope

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129337817

Cites:

Cited by:

Related to: